Cargando…

Acquisition of direct antiviral effector functions by CMV-specific CD4(+) T lymphocytes with cellular maturation

The role of CD4(+) T cells in the control of persistent viral infections beyond the provision of cognate help remains unclear. We used polychromatic flow cytometry to evaluate the production of the cytokines interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-2, the chemokine mac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casazza, Joseph P., Betts, Michael R., Price, David A., Precopio, Melissa L., Ruff, Laura E., Brenchley, Jason M., Hill, Brenna J., Roederer, Mario, Douek, Daniel C., Koup, Richard A.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118179/ https://www.ncbi.nlm.nih.gov/pubmed/17158960 http://dx.doi.org/10.1084/jem.20052246

Ejemplares similares

Autocrine Production of β-Chemokines Protects CMV-Specific CD4(+) T Cells from HIV Infection
por: Casazza, Joseph P., et al.
Publicado: (2009)

PD-1 is a regulator of virus-specific CD8(+) T cell survival in HIV infection
por: Petrovas, Constantinos, et al.
Publicado: (2006)

Avidity for antigen shapes clonal dominance in CD8(+) T cell populations specific for persistent DNA viruses
por: Price, David A., et al.
Publicado: (2005)

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses
por: Precopio, Melissa L., et al.
Publicado: (2007)

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses
por: Riou, C, et al.
Publicado: (2012)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

THE PREVALENCE OF CYTOMEGALOVIRUS (CMV) VIRURIA AMONG HOSPITALIZED CHILDREN AND THE RISK OF CMV ACQUISITION BY NURSES
por: Adler, Stuart P, et al.
Publicado: (1984)

Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023)

Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8(+) T Cells
por: Wolint, Petra, et al.
Publicado: (2004)

LB17. Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
por: Hughes, Brenna
Publicado: (2019)

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
por: Huntjens, Daan W., et al.
Publicado: (2023)

Congenital and Postnatal CMV and EBV Acquisition in HIV-Infected Zimbabwean Infants
por: Gumbo, Hlanai, et al.
Publicado: (2014)

Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
por: Wang, Xiaodong, et al.
Publicado: (2021)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection
por: Gordon, Claire L., et al.
Publicado: (2017)

Interferon-inducible antiviral effectors
por: Sadler, Anthony J., et al.
Publicado: (2008)

Avian Interferons and Their Antiviral Effectors
por: Santhakumar, Diwakar, et al.
Publicado: (2017)

The Role of Antioxidants in the Treatment of Congenital CMV-Related Hearing: A Case-Control Study
por: McCrary, Hilary, et al.
Publicado: (2019)

The Detection of CMV in Saliva Can Mark a Systemic Infection with CMV in Renal Transplant Recipients
por: Waters, Shelley, et al.
Publicado: (2019)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
por: Casazza, JP, et al.
Publicado: (2009)

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
por: Park, Ga Eun, et al.
Publicado: (2021)

Evidence for acquisition of virulence effectors in pathogenic chytrids
por: Sun, Guiling, et al.
Publicado: (2011)

Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
por: Wiening, Vanessa, et al.
Publicado: (2021)

The immunoregulatory effects of CMV-infection in human fibroblasts and the impact on cellular senescence
por: Wolf, Juliane, et al.
Publicado: (2012)

Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation
por: Lindemann, Monika, et al.
Publicado: (2021)

Humoral and Cellular CMV Responses in Healthy Donors; Identification of a Frequent Population of CMV-Specific, CD4+ T Cells in Seronegative Donors
por: Loeth, Nina, et al.
Publicado: (2012)

Oxysterols and Their Cellular Effectors
por: Olkkonen, Vesa M., et al.
Publicado: (2012)

P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
por: Letvin, N, et al.
Publicado: (2009)

Lectin-driven maturation of cytotoxic effector cells: the nature of effector memory
Publicado: (1977)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Lymphocyte Differentiation and Effector Functions
por: Olsen Saraiva Camara, Niels, et al.
Publicado: (2012)

CMV2b-AGO Interaction Is Required for the Suppression of RDR-Dependent Antiviral Silencing in Arabidopsis
por: Fang, Yuan-Yuan, et al.
Publicado: (2016)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

Interferon-stimulated genes and their antiviral effector functions
por: Schoggins, John W, et al.
Publicado: (2011)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
por: Minassian, Angela M, et al.
Publicado: (2011)

Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection
por: Geldmacher, Christof, et al.
Publicado: (2010)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

Inhibition of the TRAIL Death Receptor by CMV Reveals Its Importance in NK Cell-Mediated Antiviral Defense
por: Verma, Shilpi, et al.
Publicado: (2014)

The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis
por: Stacey, Maria A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e1lhn7nci8tq3h9bf81cumc12j